Page 5 - Pfizer

Japan approves Pfizer Covid-19 oral pills amid surging infections

Japan has granted fast-track approval to US drug maker Pfizer Inc.'s COVID-19 pill, the heath minister said Thursday, as the country struggles to slow fast-spreading omicron infections. The approval came less than a month after Pfizer applied in mid-January, an exceptional speed in a country where foreign drug approvals usually take much longer. Health Minister Shigeyuki Goto said the availability of Pfizer's Paxlovid pill gives high-risk patients, including elderly people and those with underlying health issues, greater treatment options. The approval comes as surging cases among elderly patients are starting to overwhelm hospitals in Tokyo and other metropolitan areas, and delayed booster vaccinations have reached only about 8% of the population. Most of Japan's 47 prefectures are currently under a mild version of a state of emergency. On Friday, Prime Minister Fumio Kishida announced plans to extend current restrictions in Tokyo and 12 other areas for three more weeks until Mar

GSK sees sales growth in 2022 after quarterly beat, prepares for spin-off

The results underscore a comeback for GSK in the race to help fight the Covid-19 pandemic after it failed to bring a vaccine to the market so far

Pfizer to rake in earnings of over $100 bn in Covid vax & antiviral pill

On Tuesday, the company revealed its fourth quarter earnings and revenue projections for 2022 where it said it estimates it will earn up to $102 billion in sales next year, which would be a new record

Vaccine sales pushes Pfizer beyond expectations in final quarter

Pfizer said Tuesday that it expects adjusted earnings in the new year to range from USD 6.35 to USD 6.55 per share on USD 98 billion to USD 102 billion in revenue

Pfizer net profit rises 2% at Rs 144 crore in December quarter

Drug firm Pfizer said its net profit increased by 1.89 per cent to Rs 143.91 crore for the third quarter ended December 31, 2021.

France to start using Pfizer's Covid-19 drug this week, first in EU

France says it will start administering Pfizer's coronavirus antiviral drug this week, the first pill for treating Covid-19 approved in the 27-nation EU.

Pfizer applies to USFDA for two-dose vaccine for kids under 5 years

The request for emergency authorisation comes as the highly contagious Omicron variant has led to record numbers of infections

After Pfizer, Moderna starts trial of Omicron-specific Covid vaccine

US drug maker Moderna has started trial of a Covid booster vaccine that specifically targets the Omicron variant, the company has announced.

Moderna starts trial for Omicron-specific booster shot, follows Pfizer

The coronavirus variant has quickly become dominant in many parts of the world, driving up infections and straining healthcare systems.

Pfizer begins testing omicron-matched Covid-19 shots in adults

Pfizer and its partner BioNTech announced the study on Tuesday

Pfizer and BioNTech launch trial of Omicron-targeted Covid vaccine

The companies plan to test the immune response generated by the Omicron-based vaccine both as a three-shot regimen in unvaccinated people and as a booster shot

Pfizer, CornoaVac vaccine may cause heart inflammation in adolescents

Despite low risk, there is an increased relative risk of carditis - a type of heart inflammation - associated with Covid vaccine developed by Pfizer and China's CoronaVac, researchers have found.

Annual Covid-19 vax preferred to frequent boosters, says Pfizer CEO

Albert Bourla has said Pfizer could be ready to file for approval for a redesigned vaccine to fight Omicron, and mass produce it, as soon as March

Moderna vax may lead to fewer breakthrough Covid infections than Pfizer

Those who have received the Moderna Covid-19 mRNA vaccine are less likely to experience "breakthrough" Covid-19 cases, compared to recipients of the Pfizer-BioNTech mRNA vaccine

Two Sputnik doses provide two times higher antibodies than Pfizer: Study

A study has found that two doses of Sputnik V provide two times higher virus neutralising antibodies against the Omicron variant of COVID-19 than two doses of the Pfizer vaccine

FDA may authorise Pfizer's Covid vax for kids under 5 in Feb: Fauci

The US Food and Drug Administration (FDA) is likely to approve Pfizer's Covid vaccine for children under 5 years of age in February, White House chief medical advisor Anthony Fauci has said.

Hyderabad's Biophore to manufacture ingredients of Pfizer's Covid drug

Biophore India Pharmaceutical announced that it developed and started manufacturing the key intermediates of Nirmatrelvir, one of the active ingredients of Paxlovid, the latest anti-Covid therapy

Pfizer chief Albert Bourla wins $1 mn Genesis Prize for vaccine development

Albert Bourla, chairman and chief executive of global pharmaceutical giant Pfizer Inc., was awarded the prestigious Genesis Prize for his efforts in leading the development of a Covid-19 vaccine

South Korea gets first supply of Pfizer's antiviral Covid-19 pills

Health officials have described the Paxlovid pills as a potentially important tool to suppress hospitalisations and deaths

What are the new Covid-19 vaccine platforms?

Rising cases of Covid-19 have unsettled the government. It recently approved two new vaccines. But, what is the difference between these vaccines? What platforms are used to develop them? Find out